Teladoc Health, Inc. TDOC 深 滬
等待開盤 05-22 09:30:00 美东时间
6.57
+0.090
+1.39%
華盛通- 最 高6.57
- 今 開6.35
- 成交量 317.09万股
- 最 低 6.29
- 昨 收 6.48
- 總市值 11.86亿
- 52周最高 9.77
- 市盈率 靜 --
- 換手率 1.76%
- 52周最低 4.40
- 委 比 11.11%
- 總股本 1.81亿
- 歷史最高 308.00
- 量 比 0.92
- 振 幅 4.32%
- 歷史最低 4.40
- 每 手 1
- 風險率 1.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多甲骨文发布Fusion数据智能平台，加速企业AI决策
据报道，希思罗机场、Kent集团及MTN等领先组织正利用Oracle Fusion Data Intelligence实现分析现代化，将数据转化为可衡量的业...
05-21 23:39
Cathie Wood Bets On Kalshi, But Her Ark Innovation ETF Hasn't Been Great At Timing Winners
Cathie Wood‘s ARK Invest joined Kalshi’s $1 billion Series F last week at a $22 billion valuation, slotting the prediction market behind only SpaceX and OpenAI in the ARK Venture Fund.
05-14 02:31
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6 to $7.
05-05 23:25
财报速睇 | Teladoc Health, Inc. 2026财年Q1营收6.14亿美元，同比下降2.5%；归母净利润亏损0.64亿美元，同比亏损缩窄31.4%
华盛资讯4月30日讯，Teladoc Health, Inc.公布2026财年Q1业绩，公司Q1营收6.14亿美元，同比下降2.5%，归母净利润亏损0.64亿美元，同比亏损缩窄31.4%。
04-30 22:52
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Other gainers include ABTS, AKAN, VSME, OSRH, AREB, VIAV, PI, INM, and MRAM.
04-30 17:26
Biggest stock movers Thursday: GOOG, META, QCOM, and more
Stock futures slipped on Thursday morning as geopolitical tension resurfaced, driving Brent crude to a four-year high. Investors reacted cautiously to reports that the Trump administration is weighing...
04-30 17:01
Teladoc Shares Fall After Q1 Earnings: What Investors Need To know
Teladoc stock is trading lower after reporting first-quarter financial results. Here are the highlights.
04-30 04:57
Teladoc Health Narrows FY2026 GAAP EPS Guidance from $(1.10)-$(0.70) to $(1.05)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.470B-$2.587B to $2.481B-$2.576B vs $2.509B Est.
Teladoc Health (NYSE:TDOC) narrows FY2026 GAAP EPS guidance from $(1.10)-$(0.70) to $(1.05)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.470 billion-$2.587 billion to $2.481 billion-$2.576
04-30 04:24
Teladoc Health Q1 EPS $(0.36) Misses $(0.33) Estimate, Sales $613.845M Beat $610.869M Estimate.
Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 32.08 percent increase over losses of $(0.53) per share from the
04-30 04:21
